Parkinson's disease VPS41 alpha-Synuclein Aggregation Apoptosis Mitochondria 6-Hydroxydopamine Caspase VPS41 is a protein identified as a potential therapeutic target for Parkinson's disease (PD) as a result of a high-throughput RNAi screen in Caenorhabditis elegans. VPS41 has a plausible mechanistic link to the pathogenesis of PD, as in yeast it is known to participate in trafficking of proteins to the lysosomal system and several recent lines of evidence have pointed to the importance of lysosomal system dysfunction in the neurotoxicity of alpha-synuclein (α-syn). We found that expression of the human form of VPS41 (hVPS41) prevents dopamine (DA) neuron loss induced by α-syn overexpression and 6-hydroxydopamine (6-OHDA) neurotoxicity in C. elegans. In SH-SY5Y neuroblastoma cell lines stably transfected with hVPS41, we determined that presence of this protein conferred protection against the neurotoxins 6-OHDA and rotenone. Overexpression of hVPS41 did not alter the mitochondrial membrane depolarization induced by these neurotoxins. hVPS41 did, however, block downstream events in the apoptotic cascade including activation of caspase-9 and caspase-3, and PARP cleavage. We also observed that hVPS41 reduced the accumulation of insoluble high-molecular weight forms of α-syn in SH-SY5Y cells after treatment with rotenone. These data show that hVPS41 is protective against both α-syn and neurotoxic-mediated injury in invertebrate and cellular models of PD. These protective functions may be related to enhanced clearance of misfolded or aggregated protein, including α-syn. Our studies indicate that hVPS41 may be a useful target for developing therapeutic strategies for human PD.
Introduction
Parkinson's disease (PD) is a disabling neurodegenerative disorder marked by progressive motor dysfunction and characterized by the loss of nigrostriatal dopamine (DA) neurons and cytoplasmic inclusions termed Lewy bodies (Lang and Lozano, 1998; Olanow and Tatton, 1999) . While the pathogenesis of PD has not yet been established, previous studies have implicated both genetic as well as environmental contributions. The protein alpha-synuclein (α-syn) appears to have a central role; mutations or overexpression of this protein leads to autosomal dominant PD (Singleton et al., 2003) , and accumulation of α-syn is observed even in sporadic cases of PD (Kotzbauer et al., 2004) , possibly as a result of impaired protein clearance. No treatment has yet been demonstrated to slow the rate of the neurodegenerative process in PD, and the discovery of potentially protective pathways is a high priority (Yacoubian and Standaert, 2009 ).
Animal models of PD have been constructed by overexpression of α-syn, and several of these have been used to identify factors that protect against α-syn toxicity. In a recent study, a nematode model of α-syn-induced misfolding and age-dependent DA neurodegeneration was used to screen a candidate list of ∼ 900 starting targets, derived from analysis of proteins or pathways implicated in PD, as well as coexpressed and interacting partners (Hamamichi et al., 2008) . From this screen, 20 candidate gene products were identified that, when inhibited, reproducibly led to an enhanced misfolding of human α-syn in worms. In a secondary analysis, select candidates were expressed together with α-syn in Caenorhabditis elegans DA neurons, and loss of DA neurons was assessed. One of the most effective neuroprotective proteins identified was VPS41, encoding a conserved vesicular protein necessary for lysosomal biogenesis.
VPS41 was originally identified in yeast as a member of the "class B" proteins involved in trafficking of proteins from the late Golgi to the vacuole (the yeast equivalent of the lysosome) (Bowers and Stevens, 2005) . Subsequent work has shown that VPS41 has an unusual role in yeast metabolism, in that it is required for the "ALP" pathway, which bypasses the endosome and carries only a select set of protein cargoes to the vacuole (Rehling et al., 1999) . VPS41 has metal ion binding, microtubule binding, RING finger, and AP3 interaction domains (Radisky et al., 1997) . It was suggested that the RING-H2 domain associated with a class of intracellular vesicles that originated from the Golgi (McVey Ward et al., 2001) .
